What Hologic’s Recent Performance Signals for Investors Hologic (HOLX) has drawn fresh attention after a period of steady share moves, with the stock recently closing at US$75.36. That price sits ...

Hologic’s fair value estimate has been nudged from US$76.92 to US$76.60, a small shift that keeps it closely aligned with the proposed US$79 all cash takeout price. This fine tuning mainly reflects ...

Explore five American medtech companies making global impact in 2026 through innovations in surgery, diagnostics, and population health.

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Hologic is the latest healthcare company to take a step into women’s sports, with VP of marketing Michelle Janisch noting ...

--Powerful artificial intelligence combined with digital imaging designed to transform the screening process-- Genius™ Digital Diagnostics System for Cervical Cancer Screening With the Genius Digital ...

Hologic (HOLX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Women’s health tech company Hologic is launching "Better is Possible," a new health education and awareness campaign aimed at getting women to talk to their doctors about their disruptive period ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

Hologic’s HOLX Molecular Diagnostics business posted a 7.8% (excluding COVID-19-related sales) growth in the second quarter of fiscal 2025, although results did not reflect its full potential.The ...

Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...

Though the vast majority of women are aware of the importance of early screening for various cancers and other life-threatening health conditions, a new survey estimates that nearly half of those in ...